CD44
EGFR mutation
lung cancer
polymorphism
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
25 04 2020
25 04 2020
Historique:
received:
30
03
2020
revised:
23
04
2020
accepted:
24
04
2020
entrez:
30
4
2020
pubmed:
30
4
2020
medline:
21
10
2020
Statut:
epublish
Résumé
Lung adenocarcinoma is a subtype of lung cancer with high morbidity and mortality. CD44 is instrumental in many physiological and tumor pathological processes. The expression of unique single nucleotide polymorphisms (SNPs) contributes to protein dysfunction and influences cancer susceptibility. In the current study, we investigated the relationship between
Identifiants
pubmed: 32344833
pii: ijerph17092981
doi: 10.3390/ijerph17092981
pmc: PMC7246894
pii:
doi:
Substances chimiques
CD44 protein, human
0
Hyaluronan Receptors
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Oncotarget. 2016 Jul 19;7(29):46628-46635
pubmed: 27191886
Clin Cancer Res. 2011 Apr 15;17(8):2149-58
pubmed: 21300759
J Thorac Oncol. 2014 Feb;9(2):154-62
pubmed: 24419411
Sci Rep. 2016 Dec 21;6:39485
pubmed: 28000766
PLoS One. 2014 Apr 03;9(4):e93692
pubmed: 24699672
Nucleic Acids Res. 2011 Apr;39(8):3026-41
pubmed: 21149267
PLoS One. 2014 Jul 11;9(7):e101562
pubmed: 25014510
Int J Clin Exp Pathol. 2014 Jun 15;7(7):3632-46
pubmed: 25120740
Med Sci Monit. 2015 Sep 10;21:2694-700
pubmed: 26356590
Cancer Epidemiol Biomarkers Prev. 2011 Aug;20(8):1629-37
pubmed: 21750167
Oncology. 2016;90(6):327-38
pubmed: 27225749
Breast Cancer Res. 2012 Jul 12;14(4):R105
pubmed: 22788972
Lung Cancer. 2000 Dec;30(3):153-60
pubmed: 11137199
Clin Cancer Res. 1997 Aug;3(8):1289-97
pubmed: 9815811
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
J Cell Sci. 1992 Oct;103 ( Pt 2):293-8
pubmed: 1282514
Mol Med Rep. 2016 Oct;14(4):3159-67
pubmed: 27573351
N Engl J Med. 2009 Sep 3;361(10):958-67
pubmed: 19692684
Oncotarget. 2016 Nov 8;7(45):74286-74302
pubmed: 27521214
Nat Rev Genet. 2001 Dec;2(12):930-42
pubmed: 11733746
J Hum Genet. 2007;52(11):871-880
pubmed: 17928948
Am J Cancer Res. 2015 Aug 15;5(9):2892-911
pubmed: 26609494
Biomed Res Int. 2014;2014:231474
pubmed: 24971320
Oncol Lett. 2018 Apr;15(4):5627-5633
pubmed: 29552200
Mol Pathol. 1999 Aug;52(4):189-96
pubmed: 10694938
Clin Cancer Res. 2016 Dec 15;22(24):6069-6077
pubmed: 27283965
Eur J Immunol. 1982 Aug;12(8):659-63
pubmed: 7140811
Front Cell Dev Biol. 2017 Mar 07;5:18
pubmed: 28326306
Tumour Biol. 2016 May;37(5):6971-7
pubmed: 26662954
Nucleic Acids Res. 1993 Mar 11;21(5):1225-9
pubmed: 8464707
Int J Cancer. 2011 Sep 1;129(5):1096-104
pubmed: 21105049
J Thorac Oncol. 2016 Jan;11(1):39-51
pubmed: 26762738
J Clin Lab Anal. 2019 Oct;33(8):e22977
pubmed: 31301090
Transl Lung Cancer Res. 2018 Jun;7(3):220-233
pubmed: 30050761